Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D06EMT
|
||||
| Former ID |
DAP000754
|
||||
| Drug Name |
Chlormerodrin
|
||||
| Synonyms |
Chlormerodrina; Chloromeridin; Neogidrin; Chlormerodrin Hg 197; Chlormerodrin Hg 203; Chlormerodrin (197Hg); Chlormerodrin (203Hg); Chlormerodrin Hg 197 (TN); Chlormerodrin Hg 197 (USAN); Chlormerodrin Hg 197 [USAN:USP XX]; Chlormerodrin Hg 203 (USAN); Hg-203 chlormerodrin; Loro-}; Neohydrin-203; Chlormerodrin (197Hg) (INN); Neohydrin-203 (TN); Mercury, [3-[(aminocarbonyl)amino]-2-methoxypropyl]chloro; Urea, (2-methoxypropyl)-, mercury complex; [3-(carbamoylamino)-2-methoxypropyl](chloro)mercury; [3-(carbamoylamino)-2-methoxypropyl]-chloromercury; {[3-(Chloromercuri)-2-methoxypropyl]urea}; {[3-[(Aminocarbonyl)amino]-2-hydroxypropyl]chloromercury}; [3-(carbamoylamino)-2-methoxypropyl](chloro)(203hg)mercury; [3-(carbamoylamino)-2-methoxypropyl]-chloromercury-203; Chloro(2-methoxy-3-ureidopropyl)((203)Hg)mercury(II); Mercury, {[3-[(aminocarbonyl)amino]-2-methoxypropyl]chloro-}; [3-(carbamoylamino)-2-methoxypropyl](chloro)((203)Hg)mercury; Mercury, {[3-[(aminocarbonyl)amino]-2-methoxypropyl-C1,O3]ch; (3-(Chloromercuri)-2-methoxypropyl)urea; 3-Chloromercuri-2-methoxypropylurea; 3-ureido-2-methoxypropyl((203)Hg)mercury(II) chloride
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Diagnostic imaging [ICD9: 331; ICD10:G30, I73.9] | Approved | [550714] | ||
| Therapeutic Class |
Diagnostic Agents
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C5H11ClHgN2O2
|
||||
| Canonical SMILES |
COC(CNC(=O)N)C[Hg]Cl
|
||||
| InChI |
1S/C5H11N2O2.ClH.Hg/c1-4(9-2)3-7-5(6)8;;/h4H,1,3H2,2H3,(H3,6,7,8);1H;/q;;+1/p-1/i;;1-4
|
||||
| InChIKey |
BJFGVYCULWBXKF-WUYZZQIKSA-M
|
||||
| CAS Number |
CAS 62-37-3
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | Succinate semialdehyde dehydrogenase, mitochondrial | Target Info | Modulator | [556264] | |
| BioCyc Pathway | GABA shunt | ||||
| 4-aminobutyrate degradation | |||||
| PANTHER Pathway | Aminobutyrate degradation | ||||
| Gamma-aminobutyric acid synthesis | |||||
| PathWhiz Pathway | Glutamate Metabolism | ||||
| WikiPathways | GABA synthesis, release, reuptake and degradation | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.